Individualized conservative therapeutic strategies for adenomyosis with the aim of preserving fertility
This paper discusses individualized conservative therapeutic strategies for adenomyosis to preserve fertility, aiming to improve assisted reproduction and long-term management by preserving the uterus.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews and synthesizes individualized conservative therapeutic strategies for adenomyosis, emphasizing fertility preservation in reproductive-age women, and discusses the disease’s proposed pathogenesis and major imaging diagnostic criteria using transvaginal ultrasound (FIGO 2018 features) and MRI, with surgery/biopsy noted as the gold standard. It finds that because etiology and mechanisms remain incompletely understood and there are no unified diagnostic criteria, management often focuses on long-term symptom control and reduction/avoidance of recurrence while tailoring treatment to age, ovarian reserve, severity, prior therapies, symptoms, and fertility goals. Across medication classes, it reports that NSAIDs can relieve pain but do not prevent progression and have relapse after withdrawal, while combined oral contraceptives and androgen derivatives reduce menstrual symptoms but carry cautions such as thromboembolic risk or recurrence and androgen-like adverse effects. The paper also describes progesterone-based approaches (including dienogest and dydrogesterone) as mechanisms for lowering endometrial proliferation and lesion expansion, with noted safety considerations and adverse effects, and it highlights that long-term mifepristone safety needs further verification. This paper is centrally about adenomyosis — it specifically focuses on individualized conservative therapeutic strategies aimed at preserving fertility.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
24,219 characters
· extracted from
pmc-nxml
· 9 sections
· click to expand
High
Intro
Author
Disclaimer
Conclusions
Conservative
Coi Statement
Individualized
Funding Information
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (54)
- A controlled clinical trial comparing potent progestins, LNG‐IUS and dienogest, for the treatment of women with adenomyosis via openalex
- Adenomyosis and infertility via openalex
- Adenomyosis and Infertility—Review of Medical and Surgical Approaches via openalex
- Adenomyosis: a systematic review of medical treatment via openalex
- Adenomyosis: Mechanisms and Pathogenesis via openalex
- A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis via openalex
- Clinical Efficacy and Safety of Major Uterine Wall Resection and Reconstruction of the Uterus Combined with LNG-IUS for the Treatment of Severe Adenomyosis via openalex
- Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis via openalex
- Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results via openalex
- Current and Future Medical Therapies for Adenomyosis via openalex
- Efficacy and safety of acupuncture for adenomyosis: A protocol for systematic review and meta-analysis. via openalex
- Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis via openalex
- Epidemiology of Adenomyosis via openalex
- 'Guess who'? An Italian multicentric study on pigmentation traits prevalence in endometriosis localizations via openalex
- High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up via openalex
- Hysterectomy Uniquely Impacts Spatial Memory in a Rat Model: A Role for the Nonpregnant Uterus in Cognitive Processes via openalex
- Low-dose gonadotropin-releasing hormone agonist therapy (draw-back therapy) for successful long-term management of adenomyosis associated with cerebral venous and sinus thrombosis from low-dose oral contraceptive use via openalex
- Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment via openalex
- MRI for adenomyosis: a pictorial review via openalex
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Pharmacological Treatment for Symptomatic Adenomyosis: A Systematic Review via openalex
- Relationship between adenomyosis and endometriosis; Different phenotypes of a single disease? via openalex
- Relationship between uterine volume and discontinuation of treatment with levonorgestrel-releasing intrauterine devices in patients with adenomyosis via openalex
- Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis via openalex
- Spontaneous conception and two successful pregnancies in patient who underwent conservative surgical management of diffuse uterine adenomyosis via openalex
- Spontaneous conception following GnRHa and progestogen therapy in adenomyosis via openalex
- Surgery in adenomyosis via openalex
- Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis via openalex
- The Effect of Letrozole Combined with Dydrogesterone for Endometriosis in China: A Meta‐Analysis via openalex
- The effect of transcervical endometrial resection on clinical symptoms related to intrinsic adenomyosis and junctional zone changes via openalex
- The Effects of Dienogest on Macrophage and Natural Killer Cells in Adenomyosis: A Randomized Controlled Study. via openalex
- The impact of major uterine wall resection and reconstruction of the uterus (MURU) on uterine hemodynamics and ovarian function in patients with adenomyosis: a clinical study via openalex
- The Investigation and Management of Adenomyosis in Women Who Wish to Improve or Preserve Fertility via openalex
- The Pathogenesis of Adenomyosis vis-à-vis Endometriosis via openalex
- The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis via openalex
- Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients via openalex
- Use of dienogest in endometriosis: a narrative literature review and expert commentary via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists via openalex
- Uterine artery embolisation in women with symptomatic adenomyosis via openalex
- W4292482629 via openalex
- W2891991898 via openalex
- W3007799210 via openalex
- W2042677510 via openalex
- W2790094279 via openalex
- W2752853294 via openalex
- W3204166507 via openalex
- W4200154219 via openalex
- W2338476675 via openalex
- W4200555618 via openalex
- W2100833087 via openalex
- W2071073426 via openalex
- W2043886678 via openalex
Cited by (4)
- Building Disease Models for Endometriosis: iPSCs as Game-Changers 2026
- Value of contrast-enhanced ultrasound in evaluating blood flow perfusion changes in adenomyosis patients treated with HIFU combined with leuprorelin 2025
- Integration of Bioinformatics and Pharmacological Network for Exploring the Potential of Curcumin as a Herbal Medicine for Adenomyosis 2025
- A Domain-Specific Retrieval-Augmented Generation Chatbot for Medical Queries on Adenomyosis and Endometriosis 2025
Source provenance
- europepmc
- last seen: 2026-09-21T06:08:07.822426+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-09-23T06:13:49.807636+00:00